Global Artificial Blood Market
By Product Type (Hemoglobin-Based Oxygen Carriers, Perflurocarbon-Based Products, Recombinant Factors, Synthetic Platelets, Plasma Expanders, Others),By Application (Traumatic Injuries, Blood Disorders, Anemia, Surgeries, Others), By Distribution Channel(Hospitals, Clinics, Blood Banks), and Geography –Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024
Market Outline: Artificial Blood Market
Artificial blood or synthetic blood and blood products are the alternatives to the blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in the traumatic injuries and other disease conditions for the transportation of carbon di oxide and oxygen across the body. Moreover, scientists are focusing on the development of artificial blood due to inadequate number of blood donors leads to shortage of blood. However, there are adverse effects associated with the artificial blood such as hemoglobin based blood substitute might increase the occurrence of heart attacks.
Market Dynamics: Artificial Blood Market
Drivers:
- Increase in the prevalence of anemia and traumatic injuries
- Rise in R&D for the innovation of newer products
- Growing number of surgeries combined with decrease in number of blood donors
Restraints:
- Lower shelf-life and instability of artificial blood
- Adverse effects associated with artificial blood substitutes
- Stringent regulatory guidelines for product approval
Market Scope: Artificial Blood Market
Artificial blood products market is segmented on the basis of product type, application, distribution channel, and region
Based on the product type, artificial blood market is segmented into the following:
- Hemoglobin-Based Oxygen Carriers
- Perflurocarbon-Based Products
- Recombinant Factors
- Synthetic Platelets
- Plasma Expanders
- Others
Based on the application, artificial blood market is segmented into the following:
- Traumatic Injuries
- Blood Disorders
- Anemia
- Surgeries
- Others
Based on the distribution channel, artificial blood market is segmented into the following:
- Hospitals
- Clinics
- Blood Banks
Based on the region, artificial blood market is segmented into the following:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competition Assessment: Artificial Blood Market
Some of the players in the global artificial blood include:
- Alpha Therapeutic Corp (U.S.)
- FluorO2 Therapeutics (U.S.)
- Plasticell Limited (U.K.)
Notable Market Developments: Artificial Blood Market
- In April 2017, Plasticell collaborated with Kings College London to progress the preclinical trials of artificial blood platelet product, prepared from pluripotent stem cells
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key marketdevelopments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
